BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28218976)

  • 1. Differential expression of innate immune response genes in clinical phases of chronic hepatitis B infection.
    Romani S; Hosseini SM; Mohebbi SR; Boonstra A; Sharifian A
    J Viral Hepat; 2017 Sep; 24(9):776-788. PubMed ID: 28218976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells.
    Vanwolleghem T; Hou J; van Oord G; Andeweg AC; Osterhaus AD; Pas SD; Janssen HL; Boonstra A
    Hepatology; 2015 Jul; 62(1):87-100. PubMed ID: 25808668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patients.
    Visvanathan K; Lang T; Ryan K; Wilson R; Skinner NA; Thompson AJ; Ahn SH; Weilert F; Abbott W; Gane E; Colledge D; Li K; Locarnini S; Mansell A; Revill PA
    J Viral Hepat; 2016 Mar; 23(3):170-9. PubMed ID: 26436722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alterations of IFN-γ and IL-4 of peripheral blood T cells in patients with chronic HBV infection].
    Li M; Sun X; Zhou Z; Zhang X; Jin S; Gao Y; Gao Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):240-4. PubMed ID: 26927386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response pattern varies with the natural history of chronic hepatitis B.
    Wang WT; Zhao XQ; Li GP; Chen YZ; Wang L; Han MF; Li WN; Chen T; Chen G; Xu D; Ning Q; Zhao XP
    World J Gastroenterol; 2019 Apr; 25(16):1950-1963. PubMed ID: 31086463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus (HBV) variants fluctuate in paired plasma and peripheral blood mononuclear cells among patient cohorts during different chronic hepatitis B (CHB) disease phases.
    Coffin CS; Osiowy C; Gao S; Nishikawa S; van der Meer F; van Marle G
    J Viral Hepat; 2015 Apr; 22(4):416-26. PubMed ID: 25203736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease.
    Yuan Q; Song LW; Cavallone D; Moriconi F; Cherubini B; Colombatto P; Oliveri F; Coco BA; Ricco G; Bonino F; Shih JW; Xia NS; Brunetto MR
    PLoS One; 2015; 10(6):e0130209. PubMed ID: 26115521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A serum microRNA signature is associated with the immune control of chronic hepatitis B virus infection.
    Brunetto MR; Cavallone D; Oliveri F; Moriconi F; Colombatto P; Coco B; Ciccorossi P; Rastelli C; Romagnoli V; Cherubini B; Teilum MW; Blondal T; Bonino F
    PLoS One; 2014; 9(10):e110782. PubMed ID: 25350115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dynamic changes of circulating invariant natural killer T cells during chronic hepatitis B virus infection.
    Li M; Zhou ZH; Sun XH; Zhang X; Zhu XJ; Jin SG; Jiang Y; Gao YT; Li CZ; Gao YQ
    Hepatol Int; 2016 Jul; 10(4):594-601. PubMed ID: 26924524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression and dysfunction of TLR2 and its soluble form in chronic HBV infection and its regulation by antiviral therapy.
    Huang Z; Ge J; Pang J; Liu H; Chen J; Liao B; Huang X; Zuo D; Sun J; Lu M; Zhang X; Hou J
    Antiviral Res; 2015 Jun; 118():10-9. PubMed ID: 25771704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precore/basal core promoter mutants quantification throughout phases of hepatitis B virus infection by Simpleprobe.
    Tu WH; Lv Y; Zhang YM; Hou W; Wang JY; Zhang YJ; Liu HY; Zhu HX; Qin YL; Mao RC; Zhang JM
    World J Gastroenterol; 2015 Jun; 21(21):6639-48. PubMed ID: 26074702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with chronic hepatitis B infection display deficiency of plasmacytoid dendritic cells with reduced expression of TLR9.
    Xie Q; Shen HC; Jia NN; Wang H; Lin LY; An BY; Gui HL; Guo SM; Cai W; Yu H; Guo Q; Bao S
    Microbes Infect; 2009 Apr; 11(4):515-23. PubMed ID: 19289178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver.
    Suslov A; Boldanova T; Wang X; Wieland S; Heim MH
    Gastroenterology; 2018 May; 154(6):1778-1790. PubMed ID: 29408639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of TLR1-10 expression in peripheral blood mononuclear cells with chronic hepatitis B and chronic hepatitis B-related liver failure.
    Wang K; Liu H; He Y; Chen T; Yang Y; Niu Y; Chen H; Chen Y; Liu J; Ye F; Lin S; Zhao Y
    Hum Immunol; 2010 Oct; 71(10):950-6. PubMed ID: 20667457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor-mediated immune responses are attenuated in the presence of high levels of hepatitis B virus surface antigen.
    Jiang M; Broering R; Trippler M; Poggenpohl L; Fiedler M; Gerken G; Lu M; Schlaak JF
    J Viral Hepat; 2014 Dec; 21(12):860-72. PubMed ID: 24498958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of regulatory B cells in patients with chronic hepatitis B virus infection in different immune phases.
    Wang G; Liu Y; Huang R; Jia B; Su R; Sun Z; Tian C; Xiong Y; Xia J; Yan X; Zhang Z; Wu C
    Discov Med; 2017 May; 23(128):295-304. PubMed ID: 28715645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum hepatitis B surface antigen levels in the natural history of chronic hepatitis B infection.
    Jang JW; Yoo SH; Kwon JH; You CR; Lee S; Lee JH; Chung KW
    Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1337-46. PubMed ID: 22007836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-α-induced protein 8-like 2 (TIPE2) is associated with immune phases of patients with chronic hepatitis B.
    Fan YC; Zhang YY; Wang N; Sun YY; Wang K
    Oncotarget; 2017 May; 8(19):30781-30792. PubMed ID: 28390195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of serum hepatitis B virus marker quantitation to differentiate natural history phases of HBV infection.
    Wang L; Zou ZQ; Wang K; Yu JG; Liu XZ
    Hepatol Int; 2016 Jan; 10(1):133-8. PubMed ID: 26427997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patients.
    Xu X; Shang Q; Chen X; Nie W; Zou Z; Huang A; Meng M; Jin L; Xu R; Zhang JY; Fu J; Wang L; Tang Z; Xie Y; Yang X; Zhang Z; Wang FS
    Cell Mol Immunol; 2015 May; 12(3):309-16. PubMed ID: 25849120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.